STEMLINE THERAPEUTICS (STML) SEC filings
STML SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the STML overview →
No STML SEC filing events in the measured window.
Nothing matched in the current window — the STML overview has every event we measure for this name.
Get an email when STML moves on news →Keep exploring
More STML: earnings → · analyst actions → · STML overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Revance Therapeutics, Inc. (RVNC) | 701 | 0.00% | 42% |
| AB Corporate Bond ETF (EYEG) | 700 | 0.00% | 44% |
| REGENXBIO Inc. (RGNX) | 696 | +0.35% | 54% |
| ALDER BIOPHARMACEUTICALS INC (ALDR) | 693 | -0.21% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.